Pectin in the reversal of uremia in renal failure

Pectin in the reversal of uremia in renal failure | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Case Report Pectin in the reversal of uremia in renal failure Ren Hang This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-3689543/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract The author found that pectin with a purity(the content of Gal-A (galacturonic acid)) greater than 98% has a certain therapeutic effect on patients with chronic kidney disease, especially those with renal failure and uremia. We will show the relevant results that can support the above findings through animal experiments and clinical trials respectively. We are surprised that not only can it rapidly reduce and maintain serum creatinine levels for a period of time, allowing patients to stop dialysis and stay away from dialysis, but also has amazing performance in reversing glomerular filtration rate and improving kidney size. This technology provides a new method to replace dialysis or kidney replacement therapy for patients with renal failure / uremia in the past. Clinical Pharmacology pectin chronic kidney disease glomerular filtration rate kidney size creatinine reversible Full Text Additional Declarations A statement regarding potential competing interests: Competing interests: The authors declare no competing interests. An Animal Ethics statement: We state that the Animal Ethics Committee, especially Ethics Committee of Beijing Experimental Animal Research Center has approved and supervised our study. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-3689543","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Case Report","associatedPublications":[],"authors":[{"id":258965093,"identity":"7b4786c2-7bae-40f1-848a-69f4f83e9553","order_by":0,"name":"Ren Hang","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA2ElEQVRIiWNgGAWjYBACeYbzzz8kVNjI2bc3HyBOi2HjGTaGD2fSjA14jiUQac3hM2yMM1sOJ26Q8DEgTgdj29ljj3kbDidul+D5eOMNg52cbgMBLew859KNeXekG++c3bvZcg5DsrHZAUK2zDhgIM17xlq24c7ZbdI8DAcStxHSwnD/AVBLGzNjw42cZ0RqOXDGTHJmm7Pihhs5bMRpMWw4lmwACmTJnmPGlnMMiPCLPMPhgw9AUcnP3vzwxpsKOzmCWlCABA+RUYOshVQdo2AUjIJRMCIAAN2nS8G76moiAAAAAElFTkSuQmCC","orcid":"","institution":"Ningbo Renshitang Biotechnology Co., Ltd.","correspondingAuthor":true,"prefix":"","firstName":"Ren","middleName":"","lastName":"Hang","suffix":""}],"badges":[],"createdAt":"2023-12-01 01:36:09","currentVersionCode":1,"declarations":{"humanSubjects":true,"vertebrateSubjects":true,"conflictsOfInterestStatement":true,"humanSubjectEthicalGuidelines":true,"humanSubjectConsent":true,"humanSubjectClinicalTrial":true,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":true},"doi":"10.21203/rs.3.rs-3689543/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-3689543/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[],"financialInterests":"\u003cp\u003eA statement regarding potential competing interests: Competing interests: The authors declare no competing interests. An Animal Ethics statement: We state that the Animal Ethics Committee, especially Ethics Committee of Beijing Experimental Animal Research Center has approved and supervised our study.\u003c/p\u003e","formattedTitle":"\u003cp\u003ePectin in the reversal of uremia in renal failure\u003c/p\u003e","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"Ningbo Renshitang Biotechnology Co., Ltd.","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"pectin, chronic kidney disease, glomerular filtration rate, kidney size, creatinine, reversible","lastPublishedDoi":"10.21203/rs.3.rs-3689543/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-3689543/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eThe author found that pectin with a purity(the content of Gal-A (galacturonic acid)) greater than 98% has a certain therapeutic effect on patients with chronic kidney disease, especially those with renal failure and uremia. We will show the relevant results that can support the above findings through animal experiments and clinical trials respectively. We are surprised that not only can it rapidly reduce and maintain serum creatinine levels for a period of time, allowing patients to stop dialysis and stay away from dialysis, but also has amazing performance in reversing glomerular filtration rate and improving kidney size. This technology provides a new method to replace dialysis or kidney replacement therapy for patients with renal failure / uremia in the past.\u003c/p\u003e","manuscriptTitle":"Pectin in the reversal of uremia in renal failure","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-01-02 17:58:24","doi":"10.21203/rs.3.rs-3689543/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"853634af-47b9-4809-b526-a6f4573d8452","owner":[],"postedDate":"January 2nd, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":27344957,"name":"Clinical Pharmacology"}],"tags":[],"updatedAt":"2024-01-02T17:58:24+00:00","versionOfRecord":[],"versionCreatedAt":"2024-01-02 17:58:24","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-3689543","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-3689543","identity":"rs-3689543","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}